Evidence map›Paper›PMID 41279712›Full record

ArticlebioRxiv : the preprint server for biology2025

Aged brain multi-omic integration captures immunometabolic and sex variation.

Justin P Whalley, Holly C Hunsberger, David A Bennett, Melissa Lamar, Daniel A Peterson, Grace E Stutzmann

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Justin P WhalleyCenter for Cancer Cell Biology, Immunology, and Infection, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.ORCID 0000-0002-0403-3091
Holly C HunsbergerCenter for Neurodegenerative Disease and Therapeutics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.ORCID 0000-0002-4797-9311
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Melissa LamarRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Daniel A PetersonCenter for Neurodegenerative Disease and Therapeutics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.
Grace E StutzmannCenter for Neurodegenerative Disease and Therapeutics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
Rush Alzheimer's Disease Research CenterP30AG072975 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Lisa L Barnes, Julie A. Schneider · 2021 to 2026
$24.7M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Pathway discovery, validation and compound identification for Alzheimer's disease - SupplementU01AG046152 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BENNETT, DAVID ALAN, DE JAGER, PHILIP L · 2013 to 2017
$13.6M
Alzheimer variants: Propagation of shared functional changes across cellular networksU01AG072572 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DE JAGER, PHILIP L, ST GEORGE-HYSLOP, PETER HENRY · 2021 to 2025
$8.5M
The sex specific impact of anxiety on Alzheimer's disease progressionR00AG059953 · NIA · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI HUNSBERGER, HOLLY CHRISTIAN · 2022 to 2024
$747k
Selective targeting of CNS cells in vivo for multiple transgene delivery and neuronal reprogrammingR21NS135301 · NINDS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI PETERSON, DANIEL ALAN · 2024 to 2025
$434k
Intracellular organelle deficits driving Alzheimer's diseaseR01AG065628 · NIA · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI SEKLER, ISRAEL, STUTZMANN, GRACE E. · 2024 to 2024
$431k
Generation of Parkinson-derived human glial progenitor cells for dopaminergic neuronal conversionR21NS135306 · NINDS · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI PETERSON, DANIEL ALAN · 2024 to 2024
$430k
Utilizing gene-level biomarkers of AD to identify pathophysiological mechanisms in human neuronsR21AG083638 · NIA · ROSALIND FRANKLIN UNIV OF MEDICINE & SCI · PI POTASHKIN, JUDITH ANN, STUTZMANN, GRACE E. · 2023 to 2023
$423k
NIA NIH HHS P30 AG010161NIA NIH HHS P30 AG072975NIA NIH HHS R00 AG059953NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01 AG065628NIA NIH HHS R21 AG083638NIA NIH HHS U01 AG046152NIA NIH HHS U01 AG072572NINDS NIH HHS R21 NS135301NINDS NIH HHS R21 NS135306
6 · The paper itself

Abstract

Resolving the molecular basis for heterogeneous ageing in the human brain requires integrating its diverse molecular layers. Here we applied a tensor-decomposition framework to jointly analyse single-nucleus RNA-seq, DNA methylation, H3K9ac histone acetylation and proteomic data from 276 post-mortem human cortices. The analysis uncovered two dominant, multi-omic themes. First, we identified an immunometabolic axis characterised by microglial activation, suppression of PI3K-Akt-mTOR signalling and epigenetic signatures that suggest repurposing of developmental transcription factors such as BARHL1. Second, we decomposed the effect of sex into a multi-omic program linked to cellular plasticity: although driven by canonical sex-chromosome genes, this axis was epigenetically enriched for pathways regulating stem-cell pluripotency and exhibited a female-biased shift toward precursor-like states in the oligodendrocyte lineage. Together, these findings deliver a high-resolution atlas of glial ageing and demonstrate that broad risk factors manifest as complex, cell-specific vulnerabilities; an insight critical for the development of targeted therapeutic strategies.

Identifiers

PMID41279712
PMCPMC12632994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.